MI-LINEAGE-LOGISTICS
23.3.2020 20:29:07 CET | Business Wire | Press release
Lineage Logistics Holdings, LLC (“Lineage” or the “Company”), the world’s largest and most innovative provider of temperature-controlled logistics, today announced its commitment to a $5 million donation and the launch of its Share A Meal campaign to help provide 100 million meals* to people in need in response to COVID-19.
“The COVID-19 virus presents extraordinary challenges for moving, storing, and distributing food on a large scale,” said Greg Lehmkuhl, Lineage’s President & CEO. “At Lineage, we’ve built a business dedicated to shepherding food all over the world, which puts us in a unique position to help overcome these challenges. We want to do our part by sharing what we have to offer – including temperature-controlled warehouse space, supply chain logistics expertise and financial resources.”
In honor of this response and to kick off the campaign, Lineage is donating $1 million to the Feeding America® COVID-19 Response Fund and will donate up to $500,000 more to match contributions made to the fundraiser run by Stephen and Ayesha Curry's Eat. Learn. Play. Foundation , in which all funds are directed to Feeding America ®, the nation’s largest domestic hunger-relief organization.
“We're working in a myriad of ways to ensure that every person in need, particularly the residents of Oakland, California, has access to the food they need during this COVID-19 crisis,” said Chris Helfrich, CEO of the Eat. Learn. Play. Foundation. “We're proud to be doing this work alongside Lineage Logistics – they’ve quickly established themselves as an invaluable partner in these critical times.”
“We are very proud to join forces and launch our Share A Meal campaign with Stephen and Ayesha Curry’s Eat. Learn. Play. Foundation to work with Feeding America and provide much-needed meals from coast to coast,” said Kevin Marchetti, Co-Executive Chairman of Lineage Logistics Holdings, LLC. “We hope to connect with inspirational changemakers like the Curry’s in communities across the United States and around the world in pursuit of our goal of helping to provide 100 million meals to people in need.”
In addition to these initial commitments, Lineage is looking to work closely with a number of other strategic partners to make financial and logistical contributions in communities worldwide and reach Share A Meal ’s ambitious goal.
Lineage will engage its expansive network of customers, which includes some of the world’s largest food producers and manufacturers, to join Lineage in its commitment, and the Company will challenge its investors, vendors and other likeminded leaders and businesses to donate as well as we work together to ensure people around the world have access to the feed they need. Additionally, recognizing that COVID-19 is a worldwide crisis, Lineage has engaged with the Global FoodBanking Network , to provide funds, donate food and volunteer the Company’s storage resources and distribution expertise on a global scale.
“We have the opportunity to rise to the occasion in a critical time of need and actively live out Lineage’s purpose statement of helping to feed the world,” Lehmkuhl said. “It’s a time to ask ourselves what we stand for, and how far we are willing to go in service of others. We are 14,000 strong in communities near and far. As citizens of the world, we are in this together, and we know Lineage can – and must – do more.”
*Lineage’s goal to help provide 100 million meals will include financial and in-kind donations facilitated by Lineage and its partners to Feeding America and other hunger-relief organizations. To support Lineage’s Share a Meal campaign and make a donation to Feeding America’s COVID-19 Response Fund, please visit: www.feedingamerica.org/lineage-covid
About Lineage Logistics
Lineage is the world’s largest and most innovative provider of temperature-controlled logistics solutions. Lineage’s expertise in end-to-end logistical solutions, its unrivaled facility network, and its use of technology combine to promote food safety, increase distribution efficiency, advance sustainability, lessen environmental impact, and minimize supply chain waste. As a result, Lineage helps customers ranging from Fortune 500 companies to small family-owned businesses increase the efficiency and protect the integrity of their temperature-controlled supply chain. In recognition of the company’s leading innovations, Lineage was recognized as the No 1. Data Science company on Fast Company’s Annual list of The World’s Most Innovative Companies in 2019, in addition to ranking 23rd overall in an evaluation of thousands of companies worldwide. For more information, visit: www.lineagelogistics.com .
About Feeding America®
Feeding America® is the largest hunger-relief organization in the United States. Through a network of 200 food banks and 60,000 food pantries and meal programs, we provide meals to more than 40 million people each year. Feeding America also supports programs that prevent food waste and improve food security among the people we serve; educates the public about the problem of hunger; and advocates for legislation that protects people from going hungry. Individuals, charities, businesses and government all have a role in ending hunger. Donate. Volunteer. Advocate. Educate. Together we can solve hunger. Visit www.feedingamerica.org , find us on Facebook or follow us on Twitter .
About The Global FoodBanking Network
The Global FoodBanking Network (GFN) is an international non-profit organization that nourishes the world’s hungry through uniting and advancing food banks in more than 30 countries. GFN focuses on combating hunger and preventing food waste by providing expertise, directing resources, sharing knowledge and developing connections that increase efficiency, ensure food safety and reach more people facing hunger. Last year, 943 GFN member food banks rescued over 500 million kilograms of food and grocery product and redirected it to feed 9.6 million people through a network of more than 55,000 social service and community-based organizations. For more information please visit www.foodbanking.org .
About Eat. Learn. Play.
Founded by three-time NBA champion and two-time MVP Stephen Curry and entrepreneur, host and The New York Times bestselling author Ayesha Curry, Eat. Learn. Play. Foundation seeks to unlock the human potential of every child. Focused on youth in underserved communities, the foundation's programs are anchored around three core values vital to a successful childhood: nutrition, education and physical activity. As emerging figures in the tech and food spaces, the Curry family is committed to increasing access to quality education for K-12 students, driving innovation and creativity and paving the way for bright futures. Eat. Learn. Play.'s education focus furthermore extends through college completion with a goal to close the graduation gap between low-income and minority students and their peers. The foundation's localized programs provide nutritious food for children in low-income neighborhoods to reduce childhood hunger, the tools to learn about holistic wellness and environments for safe play. In working with community partners across the country, Eat. Learn. Play. is committed to collaboratively improving lives for today's youth generation. To support Eat. Learn. Play.’s donations to the Alameda County Community Food Bank, please visit: bit.ly/elpcovidfund
View source version on businesswire.com: https://www.businesswire.com/news/home/20200323005639/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
